- Home
- HXHX vs GOVX Comparison
HXHX vs GOVX Comparison
Compare HXHX & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- GOVX
- Stock Information
- Founded
- HXHX 2003
- GOVX 2001
- Country
- HXHX China
- GOVX United States
- Employees
- HXHX N/A
- GOVX N/A
- Industry
- HXHX Trucking Freight/Courier Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- HXHX Industrials
- GOVX Health Care
- Exchange
- HXHX Nasdaq
- GOVX Nasdaq
- Market Cap
- HXHX 16.8M
- GOVX 16.8M
- IPO Year
- HXHX 2025
- GOVX N/A
- Fundamental
- Price
- HXHX $1.27
- GOVX $0.55
- Analyst Decision
- HXHX
- GOVX Strong Buy
- Analyst Count
- HXHX 0
- GOVX 3
- Target Price
- HXHX N/A
- GOVX $10.67
- AVG Volume (30 Days)
- HXHX 179.3K
- GOVX 1.3M
- Earning Date
- HXHX 11-20-2025
- GOVX 11-11-2025
- Dividend Yield
- HXHX N/A
- GOVX N/A
- EPS Growth
- HXHX N/A
- GOVX N/A
- EPS
- HXHX 0.26
- GOVX N/A
- Revenue
- HXHX $25,571,810.00
- GOVX $6,143,044.00
- Revenue This Year
- HXHX N/A
- GOVX N/A
- Revenue Next Year
- HXHX N/A
- GOVX N/A
- P/E Ratio
- HXHX $4.88
- GOVX N/A
- Revenue Growth
- HXHX N/A
- GOVX 1943.07
- 52 Week Low
- HXHX $0.84
- GOVX $0.43
- 52 Week High
- HXHX $6.29
- GOVX $3.88
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- GOVX 41.64
- Support Level
- HXHX N/A
- GOVX $0.52
- Resistance Level
- HXHX N/A
- GOVX $0.63
- Average True Range (ATR)
- HXHX 0.00
- GOVX 0.05
- MACD
- HXHX 0.00
- GOVX 0.00
- Stochastic Oscillator
- HXHX 0.00
- GOVX 55.25
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.